IL2 and chronic kidney disease: In this study, we investigated whether low-dose IL-2 could expand CD4+CD25+Foxp3+ regulatory T cells in isolated peripheral blood mononuclear cells from patients with CKD, and the role of the signal transducer and activator of transcription 5 (STAT5) pathway in the expansion.